Current status + progress
Vaccines for COVID-19 are critical tools for helping to bring the pandemic under control when combined with effective testing, treatment and existing prevention measures. Vaccinating the world against this disease is the largest vaccine procurement and supply operation in history – and UNICEF is leading this effort on behalf of the Global COVAX Facility.
More than 3.8 billion COVID-19 vaccine doses have been administered to-date. This historic global rollout is unprecedented in terms of speed, scale and demographics reached. Yet despite progress, inequities between lower and higher-income countries are continuing to cost lives and are prolonging the pandemic.
Only 16 per cent of people in low-income countries have received a single vaccine dose – compared to 80 per cent in high-income countries. In certain lower-income countries, many of the most at-risk people in society – healthcare workers, the elderly and those with underlying health conditions – are going unprotected while young, healthy adults receive booster doses in wealthier countries. The world must act urgently to close this equity gap.
UNICEF’s interactive COVID-19 market dashboard provides a regularly updated overview of the global research and development pipeline, the projected production capacity, publicly announced bilateral and multilateral supply agreements, as well as reported price points.
- What you need to know about the COVID-19 vaccine
- What parents need to know about the COVID-19 vaccine
- Resources for managing the deployment, implementation and monitoring of COVID-19 vaccines
- How UNICEF is working to ensure global equitable access to COVID-19 vaccines
COVID-19 pandemic sees 23 million children miss out on essential vaccines in 2020 – an increase of nearly 4 million from 2019
Global coverage of the third dose of diphtheria-tetanus-pertussis (DTP3) fell from 86 per cent in 2019 to 83 per cent in 2020. The latest WHO/UNICEF estimates of national immunization coverage (WUENIC) also show that 90 per cent of countries that reported 2020 data experienced stagnant or declining coverage of DTP3 compared to 2019 with nearly 30 per cent showing a decline of at least 5 percentage points. As a result, 23 million children were un- or under-vaccinated (not receiving the first dose of DTP or not receiving the third dose of DTP, respectively) in 2020. This is the highest drop in DTP3 vaccine coverage since 2008. Of those 23 million children, more than 60 per cent live in just ten countries (India, Nigeria, Democratic Republic of the Congo, Pakistan, Indonesia, Ethiopia, Brazil, Philippines, Angola and Mexico) and 17 million of them did not receive any vaccines (zero-dose children).